Search
Search Results
##search.searchResults.foundPlural##
-
SOCIOECONOMIC STATUS IS GLOBALLY A PROGNOSTIC FACTOR FOR OVERALL SURVIVAL OF MULTIPLE MYELOMA PATIENTS; SYNTHESIS OF STUDIES AND REVIEW OF THE LITERATURE SES as prognostic factor for myeloma survival
2393PDF: 960HTML: 391 -
IMPACT OF COVID-19 ON OUTCOMES OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES: A MULTI-CENTER, RETROSPECTIVE STUDY COVID-19 and hematologic malignancy
2184PDF: 911HTML: 274 -
TOLL-LIKE RECEPTORS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2787PDF: 968HTML: 17635Fig1 Caligaris: 269Fig.2 Caliga: 292 -
PERIPHERAL NERVOUS SYSTEM INVOLVEMENT IN LYMPHOPROLIFERATIVE DISORDERS
1937PDF: 969HTML: 489Fig1: 303Fig.2: 350Fig. 3: 268Fig. 5: 291Fig. 4: 304 -
CROCIN PROMOTES APOPTOSIS IN HUMAN EBV-TRANSFORMED B-LYMPHOCYTE VIA INTRINSIC PATHWAY CROCIN PROMOTES APOPTOSIS IN EBV-TRANSFORMED LCL
1497PDF: 597HTML: 316 -
Pathogen distribution, antimicrobial resistance, and mortality in febrile neutropenia among adults with hematological malignancies: a single-center cohort study
205PDF: 76Suppl. Files: 19Html: 45Html Suppl. Files: 13 -
Editorial : INTRODUCING MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES
3616PDF: 650HTML: 764 -
-
THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA
2698PDF: 897HTML: 1770 -
APPLICATION OF NEW DRUGS IN CHRONIC LYMPHOCYTIC LEUKEMIA
1788PDF: 727HTML: 2461 -
THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition
1682PDF: 1055HTML: 279 -
HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
4756PDF: 1616HTML: 8572 -
COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.
2906PDF: 1040HTML: 625 -
MILD BLEEDERS: DIAGNOSIS IS ELUSIVE IN LARGE NUMBER OF PATIENTS
3466PDF: 818HTML: 780Figure 1 Distribution of the various causes of mild bleeding (in %) in males and females: 257Figure 2 Age and Sex distribution of patients with Bleeding disorders- Unclassified: 266Table : Distribution of the sites of bleeding and their causes: 241 -
LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY Gemtuzumab ozogamicin in AML
2083PDF: 1277HTML: 359 -







